BioSpace News Archive

Business

HitGen Enters into DNA-Encoded Library Based Drug Discovery Research Collaboration with Galapagos NV

HitGen Inc. announced that it has entered into a drug discovery research collaboration with Galapagos NV to identify potential small molecule leads against targets of interest to Galapagos NV.

October 16, 2019
·
2 min read
Pharm Country

Applied DNA Partners with Molecular Isotope Technologies to Elevate CertainT® for Brand Assurance and Provenance

CertainT Platform Complemented by Stable-Isotopic Indicators Offers Brand Owners Increased Supply Chain Transparency and Product and Process Authentication

October 16, 2019
·
5 min read
Drug Development

Aurinia Reports Last Patient Study Visit in Aurora Phase 3 Lupus Nephritis Study and Provides Update on ATM Facility

AURORA Phase 3 results with voclosporin for the treatment of lupus nephritis remain on track to be reported by the end of the fourth quarter 2019

October 16, 2019
·
9 min read
Deals

Ceapro Begins Trading on the OTCQX Best MarketCompany to commence trading on the OTCQX Market effective immediately; In addition, Company will continue trading on its primary market, the TSX Venture Exchange

Ceapro Inc. announced that its common shares have been approved for trading onto the OTCQX® Best Market, a U.S. market that is operated by the OTC Markets Group in New York.

October 16, 2019
·
3 min read
Biotech Bay

Safety and Antiviral Activity of Assembly Biosciences’ First and Second Generation Core Inhibitor Candidates In the Treatment of Chronic Hepatitis B to be Featured in a Late Breaking Session at AASLD

Phase 2a studies of ABI-H0731 + nucleos(t)ide analogs (Nrtl) in HBeAg+ patients show faster and deeper declines in HBV DNA and RNA with combination than Nrtl alone, as well as subsequent declines in the surrogate markers of cccDNA with long-term treatment

October 16, 2019
·
7 min read
Potent Affron® Saffron Hits US Market

Creating a farm-to-fork controlled supply chain for Affron®'s golden saffron

October 16, 2019
·
3 min read
Genetown

SmartPharm Therapeutics Announces Presentation at the 2019 BIO Investor Forum

SmartPharm Therapeutics announced that José Trevejo, MD, PhD, Chief Executive Officer, will present at the 2019 BIO Investor Forum on Wednesday, October 23 at 9:00 a.m. PT in San Francisco..

October 16, 2019
·
1 min read
Pharm Country

OTC Markets Group Welcomes Ceapro Inc. to OTCQX

OTC Markets Group Inc. announced Ceapro Inc., a growth-stage biotechnology company focused on the development and commercialization of active ingredients for the healthcare and cosmetic industries, has qualified to trade on the OTCQX® Best Market..

October 16, 2019
·
3 min read
BioCapital

U.S. News Announces New Population Health Track for 2019 Healthcare of Tomorrow Conference

Seventh annual summit spotlights the push to prioritize community health at the national and local level

October 16, 2019
·
5 min read
Adaptate Biotherapeutics formed to develop antibody-based therapies that modulate gamma delta T-cells

GammaDelta Therapeutics spins-out new company to accelerate antibody-based assets towards clinical studies

October 16, 2019
·
3 min read